2-cyclopropyl-4-(4-methoxyphenyl)-7-[(1-methylpyrrol-2-yl)methyl]-5,6,8,9-tetrahydropyrimido[4,5-d]azepine
C24H28N4O — CID 134788875
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-cyclopropyl-4-(4-methoxyphenyl)-7-[(1-methylpyrrol-2-yl)methyl]-5,6,8,9-tetrahydropyrimido[4,5-d]azepine
2-cyclopropyl-4-(4-methoxyphenyl)-7-[(1-methylpyrrol-2-yl)methyl]-5,6,8,9-tetrahydropyrimido[4,5-d]azepine (PubChem CID 134788875) has the molecular formula C24H28N4O and a molecular weight of 388.51 g/mol. Its IUPAC name is 2-cyclopropyl-4-(4-methoxyphenyl)-7-[(1-methylpyrrol-2-yl)methyl]-5,6,8,9-tetrahydropyrimido[4,5-d]azepine.
Molecular Properties
| Compound Name | 2-cyclopropyl-4-(4-methoxyphenyl)-7-[(1-methylpyrrol-2-yl)methyl]-5,6,8,9-tetrahydropyrimido[4,5-d]azepine |
|---|---|
| PubChem CID | 134788875 |
| Molecular Formula | C24H28N4O |
| Molecular Weight | 388.51 g/mol |
| Exact Mass | 388.23 |
| IUPAC Name | 2-cyclopropyl-4-(4-methoxyphenyl)-7-[(1-methylpyrrol-2-yl)methyl]-5,6,8,9-tetrahydropyrimido[4,5-d]azepine |
| SMILES | COc1ccc(-c2nc(C3CC3)nc3c2CCN(Cc2cccn2C)CC3)cc1 |
| InChI | InChI=1S/C24H28N4O/c1-27-13-3-4-19(27)16-28-14-11-21-22(12-15-28)25-24(18-5-6-18)26-23(21)17-7-9-20(29-2)10-8-17/h3-4,7-10,13,18H,5-6,11-12,14-16H2,1-2H3 |
| InChIKey | KYSIIQNIGDBXGA-UHFFFAOYSA-N |
| XLogP | 3.97 |
| TPSA | 43.18 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 388.51 |
| LogP ≤ 5 | 3.97 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 134788875 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.